ES2883934T3 - Detección por PCR multiplex de fusiones de ALK, RET y ROS - Google Patents

Detección por PCR multiplex de fusiones de ALK, RET y ROS Download PDF

Info

Publication number
ES2883934T3
ES2883934T3 ES18730279T ES18730279T ES2883934T3 ES 2883934 T3 ES2883934 T3 ES 2883934T3 ES 18730279 T ES18730279 T ES 18730279T ES 18730279 T ES18730279 T ES 18730279T ES 2883934 T3 ES2883934 T3 ES 2883934T3
Authority
ES
Spain
Prior art keywords
exon
ros1
alk
ret
fusion gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18730279T
Other languages
English (en)
Spanish (es)
Inventor
Ann Begovich
Cindy Cheung
Javelin Chi
Grantland Hillman
Dwight Kuo
Michael Lee
Xiaoju Max Ma
Chitra Manohar
Ellen Ordinario
Jaya Rajamani
Huan Truong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62567625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2883934(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2883934T3 publication Critical patent/ES2883934T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES18730279T 2017-05-31 2018-05-30 Detección por PCR multiplex de fusiones de ALK, RET y ROS Active ES2883934T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762513226P 2017-05-31 2017-05-31
PCT/EP2018/064172 WO2018220004A1 (en) 2017-05-31 2018-05-30 Multiplex pcr detection of alk, ret, and ros fusions

Publications (1)

Publication Number Publication Date
ES2883934T3 true ES2883934T3 (es) 2021-12-09

Family

ID=62567625

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18730279T Active ES2883934T3 (es) 2017-05-31 2018-05-30 Detección por PCR multiplex de fusiones de ALK, RET y ROS

Country Status (8)

Country Link
US (2) US11505830B2 (enExample)
EP (1) EP3631011B1 (enExample)
JP (2) JP2020521440A (enExample)
CN (1) CN110691852A (enExample)
AU (1) AU2018277210B2 (enExample)
CA (1) CA3059119C (enExample)
ES (1) ES2883934T3 (enExample)
WO (1) WO2018220004A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3059119C (en) 2017-05-31 2024-01-23 F. Hoffman-La Roche Ag Multiplex pcr detection of alk, ret, and ros fusions
CN109837275B (zh) * 2019-01-08 2022-09-06 大连医科大学附属第二医院 一种融合基因阳性对照标准品的制备方法
CN111718994A (zh) * 2019-03-22 2020-09-29 广州金域医学检验中心有限公司 肿瘤融合基因靶向检测探针、试剂盒及应用
CN110964830A (zh) * 2019-12-31 2020-04-07 中山大学达安基因股份有限公司 多重检测ros1基因突变的试剂盒及方法
CN112029857A (zh) * 2020-08-14 2020-12-04 上海真固生物科技有限公司 一种引物组合物及用于融合基因检测的试剂
CN115466788A (zh) * 2022-06-28 2022-12-13 湖南圣洲生物科技有限公司 引物探针组合、试剂盒及其检测人alk、ros1基因融合的方法
CN117144016A (zh) * 2023-10-27 2023-12-01 神州医疗科技股份有限公司 一种用于外周血循环肿瘤rna中检测ret融合基因的引物探针、试剂盒及检测系统

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455170A (en) 1986-08-22 1995-10-03 Hoffmann-La Roche Inc. Mutated thermostable nucleic acid polymerase enzyme from Thermus species Z05
JP4943585B2 (ja) * 1999-02-18 2012-05-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして用いるためのサリチルアミド−ランタニド錯体
CA2405687A1 (en) * 2000-04-05 2001-10-18 Molecular Staging, Inc. Process for allele discrimation utilizing primer extension
US7385043B1 (en) 2003-04-30 2008-06-10 The Public Health Research Institute Of The City Of New York, Inc. Homogeneous multiplex screening assays and kits
ES2561406T3 (es) * 2006-04-14 2016-02-26 Cell Signaling Technology, Inc. Defectos de genes y quinasa ALK mutante en tumores sólidos humanos
JP5562640B2 (ja) * 2007-04-13 2014-07-30 セル・シグナリング・テクノロジー・インコーポレイテツド ヒト固形腫瘍における遺伝子欠失及び突然変異ａｌｋキナーゼ
US8735074B2 (en) * 2009-08-28 2014-05-27 Asuragen, Inc. MiRNA biomarkers of lung disease
US9109259B2 (en) * 2010-06-22 2015-08-18 Japanese Foundation For Cancer Research Detection method for novel ROS1 fusions
EP2599878A4 (en) * 2010-07-26 2014-02-12 Astellas Pharma Inc NEW METHOD FOR DETECTING FUSED BODIES RET
US20130059762A1 (en) * 2011-04-28 2013-03-07 Life Technologies Corporation Methods and compositions for multiplex pcr
US20130237442A1 (en) * 2012-03-07 2013-09-12 University Of Miami Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy
WO2014150300A2 (en) 2013-03-15 2014-09-25 Abbott Molecular Inc. Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits
WO2014144121A2 (en) * 2013-03-15 2014-09-18 Life Technologies Corporation Classification and actionability indices for lung cancer
US10072298B2 (en) 2013-04-17 2018-09-11 Life Technologies Corporation Gene fusions and gene variants associated with cancer
EP3825421B1 (en) 2014-03-25 2022-06-22 Quest Diagnostics Investments Incorporated Detection of gene fusions by intragenic differential expression (ide) using average cycle thresholds
CN106414768B (zh) 2014-03-27 2020-05-29 生命技术公司 与癌症相关的基因融合体和基因变异体
BR112016024672A2 (pt) 2014-04-25 2021-02-02 Exelixis, Inc método para o tratamento de adenocarcinoma de pulmão
CN104818320B (zh) * 2014-12-03 2018-02-06 厦门艾德生物医药科技有限公司 一次性检测肺癌多重基因的引物、探针、检测体系和试剂盒
CN107532209A (zh) * 2015-04-17 2018-01-02 豪夫迈·罗氏有限公司 检测基因融合的多重pcr
CA3059119C (en) 2017-05-31 2024-01-23 F. Hoffman-La Roche Ag Multiplex pcr detection of alk, ret, and ros fusions

Also Published As

Publication number Publication date
CA3059119A1 (en) 2018-12-06
CA3059119C (en) 2024-01-23
AU2018277210B2 (en) 2024-03-28
EP3631011B1 (en) 2021-06-23
JP2020521440A (ja) 2020-07-27
CN110691852A (zh) 2020-01-14
JP2024019433A (ja) 2024-02-09
US20180346994A1 (en) 2018-12-06
US11505830B2 (en) 2022-11-22
EP3631011A1 (en) 2020-04-08
WO2018220004A1 (en) 2018-12-06
US20230121541A1 (en) 2023-04-20
AU2018277210A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
ES2883934T3 (es) Detección por PCR multiplex de fusiones de ALK, RET y ROS
ES2728437T3 (es) PCR múltiple para detectar fusiones génicas
JP7111773B2 (ja) 核酸配列変種を検出するための方法
US11965212B2 (en) Nucleic acid detection combining amplification with fragmentation
ES2866026T3 (es) Método para amplificar ácido nucleico
ES2958745T3 (es) Detección mejorada de inestabilidad microsatelital
US20210010064A1 (en) Enrichment of nucleic acids
CN103459612A (zh) 用于检测野生型群体中的核酸突变体的方法和试剂盒
KR20120046018A (ko) 단일 뉴클레오티드 다형성의 실시간 ｐｃｒ 검출
US20120052501A1 (en) Kit for detecting htlv strains and use thereof
US20120045747A1 (en) Kit for detecting hepatitis b virus and method for detecting hepatitis b virus using the same
ES2943085T3 (es) Método para realizar la detección temprana de cáncer de colon y/o de células precursoras de cáncer de colon y para supervisar la recurrencia del cáncer de colon
Miyamae et al. Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue
US20120129174A1 (en) Target Sequence Amplification Method, Polymorphism Detection Method, and Reagents for Use in the Methods
US9587280B2 (en) Method for detecting a c-Met gene using cleavable probe
KR20200087726A (ko) Tert 돌연변이 검출을 위한 dna 중합효소 및 이를 포함하는 키트
KR102321902B1 (ko) Braf 돌연변이 검출을 위한 dna 중합효소 및 이를 포함하는 키트
US9157128B2 (en) Kit for detecting HIV-2 and method for detecting HIV-2 using the same
CN102369297A (zh) 识别基因型的方法
US20140093872A1 (en) Method of Mutation Detection in Blood Cell-Free DNA Using Primer Extension (PE) and PCR
BR102014029398A2 (pt) composição para reação de transcrição reversa hot-start, métodos de preparação, e kit para reação de transcrição reversa hot-start